Study reveals best timing for getting the RSV vaccine during pregnancy to protect newborns

Vaccines News

Study reveals best timing for getting the RSV vaccine during pregnancy to protect newborns
Pregnancy And ChildbirthInfant's HealthGynecology
  • 📰 ScienceDaily
  • ⏱ Reading Time:
  • 41 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 44%
  • Publisher: 53%

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for infants -- during weeks 32-36 of pregnancy.

Study reveals best timing for getting the RSV vaccine during pregnancy to protect newborns." ScienceDaily. ScienceDaily, 11 November 2024. <www.sciencedaily.comMass General Brigham. . Study reveals best timing for getting the RSV vaccine during pregnancy to protect newborns.

Vaccinating mothers against respiratory syncytial virus during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes. Infants ... On the heels of a shortage of nirsevimab for infant respiratory syncytial virus lower respiratory tract infection prevention, a new tool may help identify newborns at highest risk for ...

A new tool to identify infants most at risk for severe respiratory syncytial virus illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV ... Nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus in healthy infants, according to an international, ...LIVING & WELL

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ScienceDaily /  🏆 452. in US

Pregnancy And Childbirth Infant's Health Gynecology Teen Health Diseases And Conditions Smoking Today's Healthcare

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study Confirms RSV Vaccine's Protective Power for SeniorsStudy Confirms RSV Vaccine's Protective Power for SeniorsA global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization.
Read more »

Groups With Highest Unmet Need for PrEP Highlighted in AnalysisGroups With Highest Unmet Need for PrEP Highlighted in AnalysisLarge study showed current statistical trends of PrEP access vs PrEP need.
Read more »

Pregnant Wolverhampton women offered RSV vaccine to help newbornsPregnant Wolverhampton women offered RSV vaccine to help newbornsWomen who are at least 28 weeks pregnant are eligible for the respiratory syncytial virus vaccine
Read more »

RSV, Flu and COVID-19 season is here, so do you need three vaccines?RSV, Flu and COVID-19 season is here, so do you need three vaccines?COVID-19, influenza and RSV are the main threats between October and May. There are vaccines for all three viruses, but which do you need?
Read more »

RSV Vaccine Shows Strong Protection for Older AdultsRSV Vaccine Shows Strong Protection for Older AdultsA large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or needing intensive care unit support for severe complications.
Read more »

FDA approves Pfizer's RSV vaccine for adults at increased risk of the diseaseFDA approves Pfizer's RSV vaccine for adults at increased risk of the diseaseThe U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease.
Read more »



Render Time: 2025-02-15 12:03:26